<HTML>
<HEAD>
<TITLE>AOD Thesaurus Annotated Hierarchy: chemical substances by function YW YZ20</TITLE>
<META
Name="Description"sA Guide to Concepts and Terminology in Substance Abuse and Addiction">
</META>
<META
Name="Keywords"
Content="classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept">
</META>
</HEAD>
<body bgcolor="#FFFFFF">
<CENTER><B><BIG>AOD Thesaurus.&nbsp;&nbsp;Annotated Hierarchy.&nbsp;&nbsp;chemical substances by function.&nbsp;&nbsp;YW - YZ20</BIG></B></Center>
<CENTER><A HREF="aodob.htm#Y">b-out</A>&nbsp;&nbsp;To Broad Outline&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#YW">d-out</A>&nbsp;&nbsp;To Detailed Outline&nbsp;&nbsp;&nbsp;&nbsp;
<A HREF="aodhqy.htm">qh</A>&nbsp;&nbsp;To Quick Hierarchy</CENTER>
<CENTER><A HREF="aodhnyn.htm">Previous</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm">Next</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodwsrch.htm">Search</A></CENTER><BR><BR>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW"><B><BIG>YW</BIG></B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B><BIG>CNS agents</BIG></B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#YW"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="25%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Drugs that act upon the central nervous system.  They may selectively relieve pain or fever, suppress disorders of movement, or prevent seizures.  They may induce sleep or arousal and the desire to
   eat, or may allay the tendency to vomit.  They may be used to treat anxiety, mania, depression, or schizophrenia without altering consciousness.  Socially acceptable stimulants and antianxiety
   agents produce stability, relief, and even pleasure for many.  However, the excessive use of these and other drugs can adversely affect lives when their use leads to physical dependence or to toxic
   side effects, which may include lethal overdose. 
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Many CNS agents also act on the peripheral nervous system and other body systems.  Conversely, the brain may be affected by drugs that are used to treat
   peripheral organs.  Consequently, classification categories are blurred and overlapping. 
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Thesaurus concentrates on psychoactive substances; drugs to treat epilepsy or Parkinson's disease, to mention two other uses of CNS agents, are not
   covered.  Section YW is the main home for substances that are important because of their therapeutic uses; AOD substances have their main home in section B and are cross-referenced here.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> central nervous system agent </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> centrally acting drugs </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+Be AOD substance or product &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#B"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#B"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BT4e illicit drug &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW2"><B>YW2</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>psychoactive substances</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A substance that, when ingested, affects mental processes (e.g., cognition or memory).  This term and its equivalent, psychotropic drugs, are the most neutral and descriptive terms for the whole
   class of substances, whether licit or illicit, of interest to drug policy.  "Psychoactive" does not necessarily imply dependence-producing.  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This term is preferred by many to refer to drugs that affect the central nervous system and alter mood, perception, or consciousness; it is preferred as a
   substitute for "drug" because of the value-laden connotations and denotative confusions surrounding the latter term.  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Terminological notes:  The term "psychotropic agent" or "psychotropic drug" is ambiguous, as the WHO Lexicon entry shows: A psychotropic drug is any chemical
   agent whose primary or significant effects are on the central nervous system.  Some writers apply the term to drugs whose primary use is in the treatment of mental disorders (e.g., anxiolytic
   sedatives, antidepressants, antimanic agents, and major tranquilizing agents).  Others use the term to refer to substances with a high abuse potential because of their effects on mood or
   consciousness or both (e.g., stimulants; hallucinogens; opioids; sedatives; and hypnotics, including alcohol).  The NIDA entry, on the other hand, states: Term sometimes used broadly to refer to
   psychoactive substances; more generally used to refer just to the psychotherapeutic drugs.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> agents affecting mood and behavior </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> narcotics (any psychoactive drug) </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> psychoactive agents </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> psychoactive drugs </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> psychotropic agents </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> psychotropic drugs </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+Be AOD substance or product &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#B"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#B"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW2-2">YW2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>psychopharmaceuticals&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A pharmaceutical that is a psychoactive drug.  Not all psychopharmaceuticals are used for treating behavioral and mental disorders.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW2-2-2">YW2.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>psychotherapeutic agents&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.  ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Drugs used to treat behavioral and mental disorders. 
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Drugs that (1) are used as medications to alleviate psychic distress or as adjuncts to treatment of various physical disorders, and (2) are typically acquired
   through a doctor's prescription or over the counter at a drugstore.  An older and less preferred term for such drugs is "psychotropics".
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> psychotherapeutic drugs </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> psychotherapeutics </TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4"><B>YW4</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>CNS depressants</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Any agent that suppresses, inhibits, or decreases some aspects of central nervous system (CNS) activity.  The main classes of depressants are the sedatives/hypnotics, opioids, and major tranquilizing
   agents (neuroleptics).  Examples of depressant drugs include alcohol, barbiturates, anesthetics, benzodiazepines, opiates, and their synthetic analogs.  Anticonvulsants are sometimes included in
   the depressant group because of their inhibitory action on abnormal neural activity.  Refer to specific substances such as *+ZT6.4.2 benzodiazepines* <A
   HREF="aodhqz.htm#ZT6-4-2"><SMALL>qh</SMALL></A> <A HREF="aodhnzt.htm#ZT6-4-2"><SMALL>ah</SMALL></A>, *+ZQ opioids* <A HREF="aodhqz.htm#ZQ"><SMALL>qh</SMALL></A> <A
   HREF="aodhnzp.htm#ZQ"><SMALL>ah</SMALL></A>, *+YW4.10.2 antipsychotic tranquilizers* <A HREF="aodhqy.htm#YW4-10-2"><SMALL>qh</SMALL></A> <A HREF="aodhnyw.htm#YW4-10-2"><SMALL>ah</SMALL></A>, and
   *+YW4.8 sedative-hypnotics* <A HREF="aodhqy.htm#YW4-8"><SMALL>qh</SMALL></A> <A HREF="aodhnyw.htm#YW4-8"><SMALL>ah</SMALL></A>.  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Disorders related to depressant use are classified in ICD-10 as "psychoactive substance use disorders" and divided between alcohol (F10), opioids (F11), and
   sedatives or hypnotics (F13).
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> central nervous system depressants </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+BB2e ethanol &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BB2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BB2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BGe volatile inhalant &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BG"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BG"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BH CNS depressants of abuse &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BH"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BH"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT4.28.6.6e barbiturates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-28-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+Be AOD substance or product &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#B"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#B"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BF6e phencyclidine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BF6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BF6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW12 narcotic agonists and antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-2">YW4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>narcotic analgesics&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Changed descriptor 1995; through 1995 also use "narcotics."
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Narcotic analgesics relieve pain by altering the patient's perception; they are most often used for severe pain.  "Narcotics" often is used with the narrow meaning of opioid or narcotic analgesics. 
   See the scope note for *+YW2 psychoactive substances* <A HREF="aodhqy.htm#YW2"><SMALL>qh</SMALL></A> <A HREF="aodhnyw.htm#YW2"><SMALL>ah</SMALL></A> for observations on terminology.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> addictive analgesics </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> narcotic agonists </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> narcotic analgesic agonists </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> narcotics (analgesics) </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> opioid analgesics </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+BL opioids in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BL"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BL"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BL4.2e opium &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BL4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BL4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZJ2.6.6.2.2e propoxyphene &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-6-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-6-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.2.2e morphine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.2.6e dihydromorphine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.2.8e dihydromorphinone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.2.12 oxymorphone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-2-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.4.2e codeine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.4.4e hydrocodone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.4.6e oxycodone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.8.2e levorphanol &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ8.2e meperidine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ10.2e methadone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ10.4e LAAM &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16e opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.10 fentanyl &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YR2e analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YR2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YR2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW12 narcotic agonists and antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-4">YW4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>general anesthetics&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995. Through 1995 also use *+YR4 anesthetics* <A HREF="aodhqy.htm#YR4"><SMALL>qh</SMALL></A> <A HREF="aodhnyn.htm#YR4"><SMALL>ah</SMALL></A>.
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Drugs that produce absence of perception of all sensation, especially of pain, in the entire body and may produce loss of consciousness.  While a number of drugs (e.g., barbiturates and cocaine) have
   anesthetic properties, the principal general anesthetics are the vaporous chloroform and ether, and the gaseous nitrous oxide.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZC12.8.10e nitrous oxide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZC12-8-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZC12-8-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZF6e ethers &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZF6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZF6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZJ2.6.10.2.4.2e sodium oxybate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-6-10-2-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-6-10-2-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZL2.6.4e chloroform &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZL2-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZL2-6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT4.28.6.6e barbiturates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-28-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YR4e anesthetics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YR4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YR4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-4-2">YW4.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>dissociative anesthetics&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> anesthetic, dissociative </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>BF6e phencyclidine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BF6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BF6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZE2.2.2.2.2e ketamine hydrochloride &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZE2-2-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZE2-2-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-6">YW4.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>anticonvulsants&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZF8.10.2.4e dizocilpine maleate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZF8-10-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZF8-10-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZJ2.6.12.2.2e valproate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-6-12-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-6-12-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZN6.2e succinimide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT4.14.6e hydantoin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-14-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-14-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.16.6e trimethadione &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-16-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-16-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT4.28.6.6e barbiturates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-28-6-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-8">YW4.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>sedative-hypnotics&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Changed descriptor 1995; through 1995 also use "sedatives."
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Any of a group of central nervous system depressants with the capacity of relieving anxiety and inducing calmness and sleep.  Several such drugs also induce amnesia and muscle relaxation, and/or have
   anticonvulsant properties.  Major classes of sedative/hypnotics include the benzodiazepines and the barbiturates.  Also included are alcohol, buspirone, chloral hydrate, acetylcarbromal,
   glutethimide, methyprylon, ethchlorvynol, ethinamate, meprobamate, and methaqualone.  Some authorities use this term only for a subclass of these drugs used to calm acutely distressed persons or to
   induce sleep, and distinguish them from minor tranquilizers used for the treatment of anxiety. 
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Disorders resulting from sedatives or hypnotics" (F13) is one of the substance use disorders in ICD-10.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> hypnotics </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> sedative/hypnotics </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> sedatives </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+BBe alcohol in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BB"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BB"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BB2e ethanol &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BB2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BB2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV6.4.2e histamine H1 receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.10e tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZJ2.6.10.4.2e meprobamate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-6-10-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-6-10-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.28.2e buspirone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-28-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+Be AOD substance or product &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#B"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#B"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>HU4.4 general anesthesia &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HU4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HU4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZF6e ethers &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZF6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZF6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZG2.4.2e paraldehyde &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZG2-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZG2-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZL2.4e halothane &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZL2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZL2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT4.28.6.6e barbiturates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-28-6-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-8-2">YW4.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>barbiturate sedative-hypnotics&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> barbiturate hypnotics </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> barbiturate sedatives </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZT4.28.6.6e barbiturates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-28-6-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-8-2-2">YW4.8.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>long-acting barbiturates&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZT4.28.6.6.6e barbital &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-28-6-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.28.6.6.12e phenobarbital &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-28-6-6-12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-8-2-4">YW4.8.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>intermediate-acting barbiturates&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZT4.28.6.6.4e amobarbital &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-28-6-6-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-8-2-6">YW4.8.2.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>short-acting barbiturates&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZT4.28.6.6.10e pentobarbital &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-28-6-6-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.28.6.6.16e secobarbital &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-28-6-6-16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.28.6.6.18.4e thiopental &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-6-18-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-28-6-6-18-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-8-4">YW4.8.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nonbarbiturate sedative-hypnotics&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> nonbarbiturate sedatives </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZF2.4.2.4 chloral hydrate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZF2-4-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZF2-4-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZF4.4e propofol &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZF4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZF4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZG2.4.2e paraldehyde &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZG2-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZG2-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZJ2.10.10.6.2.2e thalidomide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-10-10-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-10-10-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.20.8.4e glutethimide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-20-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-20-8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.4.2.14e triazolam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.20.4e methaqualone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-20-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-20-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YV6.4.2e histamine H1 receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV6-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV6-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-8-6">YW4.8.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>antianxiety tranquilizers&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Also called minor tranquilizers, this term was introduced to distinguish these drugs from the "major tranquilizers" (neuroleptics) used for the treatment of psychotic disorders.  Minor tranquilizing
   agents are used in the treatment of anxiety disorders.  The term "minor tranquilizer" has been incorrectly assumed to indicate an absence of harmful effects.  There still is dependence potential in
   these drugs.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> antianxiety agents </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> anxiolytic agents </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> anxiolytics </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> minor tranquilizers </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZJ2.6.10.4.2e meprobamate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-6-10-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-6-10-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.28.2e buspirone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-28-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT8.8.2e doxepin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YW4.10e tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-8-6-2">YW4.8.6.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>benzodiazepine tranquilizers&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">RT</TD><TD>+ZT6.4.2e benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-8-6-2-2">YW4.8.6.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>short-acting benzodiazepines&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZT6.4.2.2e alprazolam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.4.2.8.16e flunitrazepam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-8-16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.4.2.8.20e lorazepam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-20"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-8-20"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.4.2.8.22e nitrazepam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-22"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-8-22"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.4.2.8.24e oxazepam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-24"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-8-24"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.4.2.8.30e temazepam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-30"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-8-30"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.4.2.8.32e halazepam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-32"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-8-32"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.4.2.14e triazolam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-8-6-2-4">YW4.8.6.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>long-acting benzodiazepines&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">NT</TD><TD>+ZT6.4.2.8.12e diazepam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-8-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.4.2.8.18e flurazepam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-8-18"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.4.2.8.28e prazepam &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-8-28"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-8-28"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT6.4.2.10e chlordiazepoxide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.4.2.10.2e clorazepate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2-10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-10">YW4.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>tranquilizers&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Changed descriptor 1995; through 1995 also use "tranquilizing agents."
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>A general term for several classes of drugs employed in the symptomatic management of various mental disorders.  The term can be used to differentiate between these drugs and the sedatives:  The
   tranquilizers have a quieting or dampening effect on the psychomotor processes without--except at high doses--interfering with consciousness and thinking.  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Currently, the term tranquilizer is used mainly to refer to drugs used for the treatment of anxiety disorders, synonymous with the term "minor tranquilizer".
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+YP2.8.12.4 agents for AOD-concurrent anxiety &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP2-8-12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP2-8-12-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.12.8 agents for alcohol-concurrent anxiety &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YP6.8.8.4 agents for sedative-hypnotic-concurrent anxiety &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP6-8-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP6-8-8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP10.8.10.4 agents for cocaine-concurrent anxiety &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YP12.8.10.4 agents for opiate-concurrent anxiety &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP12-8-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP12-8-10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.8.6e antianxiety tranquilizers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZA2.4.2.2e lithium &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZA2-4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZA2-4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YW4.8e sedative-hypnotics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-10-2">YW4.10.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>antipsychotic tranquilizers&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>A class of medications used for the treatment of acute and chronic psychoses.  Also known as major tranquilizers, antipsychotics, and neuroleptics.  Major tranquilizing agents include the
   phenothiazines (e.g., chlorpromazine, thioridazine, fluphenazine) and the butyrophenones (e.g., haloperidol) and have low abuse potential.  See *GC2.6 abuse of non-dependence-producing substance*
   <A HREF="aodhqg.htm#GC2-6"><SMALL>qh</SMALL></A> <A HREF="aodhng.htm#GC2-6"><SMALL>ah</SMALL></A>.  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Antipsychotic tranquilizers all have certain common biochemical characteristics in their molecular structure and the pharmacological property of being an
   antagonist to the brain chemical dopamine.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> antipsychotic agents </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> major tranquilizers </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> neuroleptics </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZT4.20.4e penfluridol &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-20-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-20-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.28.6.2e risperidone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-28-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-28-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.6.2e pimozide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT8.4.2.2e clozapine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT8.12.2e thiothixene &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT8.16.2.2e flupenthixol &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-16-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-16-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-10-2-2">YW4.10.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>butyrophenone tranquilizers&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZG4.4.2e haloperidol &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZG4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZG4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW4-10-2-4">YW4.10.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>phenothiazine tranquilizers&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-10-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZT8.14.2e chlorpromazine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-14-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT8.14.4e perphenazine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-14-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT8.14.6e prochlorperazine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-14-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT8.14.8e promazine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-14-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT8.14.12e thioridazine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-14-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT8.14.14e trifluoperazine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-14-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-14-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW6"><B>YW6</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>antidepressants</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Changed descriptor 1995; through 1995 also use "antidepressive agents."
  </TD></TR>
<TR><TD WIDTH="25%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>A major classification of drugs that were developed recently, are sold only by prescription, and are used medically to improve mood in severely depressed patients.  Generally divided into the
   tricyclic compounds amitriptyline hydrochloride and imipramine hydrochloride and the MAO inhibitors; rarely used for nonmedical purposes since they have little immediate pleasurable effect on
   normal mood states.  This varied group of drugs seems to have a stimulant effect in cases of pathologic depression but appears to have little effect in normal states.  Chronic usage, however, has
   been shown to have clearly defined stimulatory action.  Although some of the stimulants have been medically used as antidepressants, their effects are inconsistent.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> antidepressive agents </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+BK2e cocaine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BK2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BK2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP2.8.12.2 agents for AOD-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP2-8-12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP2-8-12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.12.6 agents for alcohol-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YP6.8.8.2 agents for sedative-hypnotic-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP6-8-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP6-8-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP10.8.10.2 agents for cocaine-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YP12.8.10.2 agents for opiate-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP12-8-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP12-8-10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZN2.20.6.10e sulpiride &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-6-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-20-6-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT4.26.4.2.2e zimelidine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-26-4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.12.6e nomifensine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-12-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW6-2">YW6.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>tricyclic antidepressants&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A group of psychoactively therapeutic agents prescribed for the treatment of depressive disorders.  Tricyclic antidepressants principally are inhibitors of noradrenaline uptake.  They have a low
   abuse potential, but sometimes are used nonmedically for their immediate psychic effects.  Tolerance develops to their anticholinergic effects but it is doubtful whether a dependence syndrome or
   withdrawal syndrome occurs.  For these reasons, misuse of antidepressants is included in category F55 of ICD-10, "abuse of nondependence producing substances".  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Examples include imipramine, amitriptyline, and desipramine.
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>A major category of antidepressants.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> tricyclic antidepressive agents </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+YW6.4e MAO inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZF8.10.2.6e nortriptyline &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZF8-10-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZF8-10-2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT8.2.2.4e imipramine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-2-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-2-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT8.2.2.6e desipramine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-2-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-2-2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+GZ6.4.4e affective psychosis &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GZ6-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngz.htm#GZ6-4-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW6-2-2">YW6.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tianeptine&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW6-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP2.8e AOD relapse prevention agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP2.8.12.2 agents for AOD-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP2-8-12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP2-8-12-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW6-4">YW6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>MAO inhibitors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Monoamine oxidase inhibitors; antidepressants chemically related to the amphetamines and used as psychic mood elevators, particularly in the treatment of psychotic depression.  Potent, unpredictable
   drugs, they are capable of producing a variety of dangerous side effects.  Deaths have resulted from their administration in conjunction with the following substances, whose effects they
   potentiate:  alcohol,  amphetamines, depressants, antihistamines, sedatives, anesthetic drugs, and insulin.  MAO inhibitors are divided into two categories:  (1) the hydrazine type such as
   isocarboxazid, nialamide, and phenelzine sulfate; and (2) nonhydrazine type, such as tranylcypromine sulfate.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> monoamine oxidase inhibitors </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YD8e enzyme inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YD8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YD8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.12.6 agents for alcohol-concurrent depression &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW6.2 tricyclic antidepressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>YC14.8.2e monoamine oxidase &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YC14-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YC14-8-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW6-4-2">YW6.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>phenelzine&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW6-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A MAO inhibitor, manufactured as Nardil.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> Nardil </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.8.12.8 agents for alcohol-concurrent anxiety &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW8"><B>YW8</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>CNS stimulants</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>In reference to the central nervous system, any agent that activates, enhances, or increases neural activity.  Also called psychostimulants.  These drugs include the amphetamines; cocaine; caffeine
   and other xanthines; nicotine; and synthetic diet suppressants, such as phenmetrazine or methylphenidate.  Other drugs have stimulant actions that are not their primary effect but which may be
   manifest in high doses or after chronic use; they include antidepressants, anticholinergics, and certain opioids.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> analeptics </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> central nervous system stimulants </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> ergogenics </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> psychostimulants </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> stimulants </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>BC2e caffeine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BC2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BC2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BD2e nicotine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BJ CNS stimulants of abuse &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BJ"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BJ"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BJ2.2e amphetamines &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BJ2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BJ2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BK2e cocaine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BK2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BK2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV8e parasympatholytics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZC12.8.4e nitric oxide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZC12-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZC12-8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZN2.16.2.12.4.4e ephedrine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-16-2-12-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-16-2-12-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT4.16.4e pemoline &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-16-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-16-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.16.4.2e magnesium pemoline &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-16-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-16-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT6.18.2.2e xanthines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-18-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-18-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW8-2">YW8.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>primary stimulants&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+BJ2 primary stimulants of abuse &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BJ2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BJ2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW8-4">YW8.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>secondary stimulants&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+BJ4 secondary stimulants of abuse &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BJ4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BJ4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW8-6">YW8.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>convulsants&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW8-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZP2e bicuculline &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZP22e strychnine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP22"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP22"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.2.2e pentylenetetrazole &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW8-6-2">YW8.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>picrotoxin&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW8-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW10"><B>YW10</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>hallucinogens</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A major classification of natural and synthetic drugs whose primary effect is to distort the senses; they can produce hallucinations (i.e., experiences that depart from reality).  These drugs may
   produce profound alterations in sensation, mood, and consciousness at doses that result in comparatively light physiological activity.  Although most experiences are visual, they also may involve
   the senses of hearing, touch, smell, or taste, sometimes simultaneously.  They also are variously known as psychedelic (i.e., mind-manifesting), psychotomimetic (i.e., psychosis-imitating),
   illusionogenic (i.e., illusion-producing), psychotaraxic, and psychodysleptics (i.e., mind-disrupting) drugs.  These terms refer to somewhat overlapping effects alleged to occur with this group of
   drugs, probably none of which are entirely adequate as descriptive terms.  Psychedelic is the preferred term of users, but hallucinogen has gained the widest support.  Included in this
   classification are dimethyltryptamine (DMT), lysergic acid diethylamide (LSD), methylenedioxyamphetamine (MDA), mescaline, peyote, phencyclidine (PCP), psilocybin, psilocin, and
   dimethoxymethylamphetamine (STP, DOM).  The term also has been applied to the pseudohallucinogens, such as nutmeg and mace.  While other drugs, such as alcohol or cannabis, may produce
   hallucinations if a very high dose is used, they are not classified as hallucinogens because this is not the usual effect expected or experienced.  At low doses, the effects of hallucinogens vary
   widely, depending on variations in the drug taken and the unique sensitivity of the user at the time of use.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> psychedelic substances </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> psychotomimetics </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+BF hallucinogens of abuse &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BF"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BF"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BF2.2 mescaline &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BF2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BF2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BF6e phencyclidine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BF6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BF6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BF8.4 psilocybine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BF8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BF8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BGe volatile inhalant &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BG"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BG"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BJ2.10 DOM &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BJ2-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BJ2-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BT6.4.2 schedule II hallucinogens &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZP10e ibogaine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT8.8.4e harmine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZU4e cannabinoids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZU4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzu.htm#ZU4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+BF hallucinogens of abuse &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BF"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BF"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>GD2.2.12 flashbacks &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GD2-2-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhng.htm#GD2-2-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>GZ2.4.6 hallucination &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GZ2-4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngz.htm#GZ2-4-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW12"><B>YW12</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>narcotic agonists and antagonists</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="25%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Narcotic agonists are the same as *+YW4.2 narcotic analgesics* <A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A> <A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A>, which have their home location under
   *+YW4 CNS depressants* <A HREF="aodhqy.htm#YW4"><SMALL>qh</SMALL></A> <A HREF="aodhnyw.htm#YW4"><SMALL>ah</SMALL></A>.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+YW4.2e narcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW12-2">YW12.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>narcotic antagonists&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW12-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>A drug that blocks or counteracts the effects of opioid narcotics.  Many have been derived by chemically altering some aspects of natural or synthetic opiate narcotics.  Among the best known
   antagonists are cyclazocine, naloxone, nalorphine, and naltrexone.  In sufficient doses, narcotic antagonists can block the psychological effects of opiate narcotics, including the development of
   tolerance and (physical) dependence, and can reverse or prevent toxic effects.  They also can precipitate an intense acute withdrawal syndrome in opiate-narcotic-dependent individuals who have not
   been detoxified, and this property sometimes is employed for identifying physically dependent persons for medical and legal purposes.  Narcotic antagonists may be pure or mixed.  The pure narcotic
   antagonists (e.g., naltrexone and naloxone) in reasonable doses will produce little effect on an opiate-detoxified or nonopiate-dependent person.  The mixed, or partial, narcotic antagonists (e.g.,
   cyclazocine, nalorphine, and pentazocine) have slight narcotic agonist properties and their cessation will induce withdrawal symptoms in a user who has developed a physical dependence on opiates.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> opioid antagonists </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EE16.6e antagonistic drug interaction &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE16-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW12-2-2">YW12.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pure narcotic antagonists&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW12-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZQ4.6.4e naloxone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.6.6e naltrexone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.8.4e levallorphan &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.8.6e nalmefene &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-8-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YW12-2-4">YW12.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>mixed narcotic agonists and antagonists&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW12-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZQ6.2e buprenorphine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX"><B><BIG>YX</BIG></B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B><BIG>toxic substances</BIG></B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#YX"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">ST</TD><TD> hazardous chemicals </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> hazardous materials </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> poisons </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> toxic material </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+OA technology, manufacturing, and agriculture &nbsp;&nbsp;&nbsp;<A HREF="aodhqo.htm#OA"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhno.htm#OA"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+OR4e safety &nbsp;&nbsp;&nbsp;<A HREF="aodhqo.htm#OR4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhno.htm#OR4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EB10e drug metabolism &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+OR safety and accidents &nbsp;&nbsp;&nbsp;<A HREF="aodhqo.htm#OR"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhno.htm#OR"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+PZ2.4 environmental pollution &nbsp;&nbsp;&nbsp;<A HREF="aodhqpm.htm#PZ2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnpm.htm#PZ2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX2"><B>YX2</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>toxins</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">RT</TD><TD>+YMe other biological factors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YM"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YM24.2 toxoids &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM24-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YM24-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX2-2">YX2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>bacterial toxins&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX2-4">YX2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>cytotoxins&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD>+ZO6.8.12.16e tumor necrosis factor &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO6-8-12-16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO6-8-12-16"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX2-6">YX2.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>endotoxins&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> bacterial pyrogen </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX2-8">YX2.8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>enterotoxins&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX2-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX2-10">YX2.10</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>marine toxins&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX2-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX2-10-2">YX2.10.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tetrodotoxin&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX2-10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX2-12">YX2.12</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>mycotoxins&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX2-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZJ2.6.14.2e penicillic acid &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-6-14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-6-14-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZO4.8.6e phalloidine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO4-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO4-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.22.2e patulin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-22-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-22-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX2-14">YX2.14</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>neurotoxins&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX2-14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EE14.4.4.4.2.4e neurotoxicity &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-4-4-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-4-4-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX4"><B>YX4</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>carcinogens</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZF8.14e pyrene &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZF8-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZF8-14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZJ2.6.14.2e penicillic acid &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-6-14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-6-14-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZK10.2.2 croton oil &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZK10-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZK10-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZN2.20.2.2.4e thioacetamide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-2-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-20-2-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZN2.20.6.8e procarbazine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-20-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-20-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZP16e pyrrolizidine alkaloids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.22.2e patulin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-22-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-22-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZU10.4e phorbol &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZU10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzu.htm#ZU10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>GG20.28.2e carcinogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GG20-28-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngf.htm#GG20-28-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX4-2">YX4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>nitroso compounds&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX4-2-2">YX4.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nitrosamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZN2e amines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX4-2-2-2">YX4.2.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>dimethylnitrosamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX4-2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> N nitrosodimethylamine </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> nitrosodimethylamine </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX4-4">YX4.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>tar&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD>+BDe tobacco in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BD4e tobacco product &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX4-4-2">YX4.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>cigarette tar&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+BD4.2e cigarette &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX6"><B>YX6</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>teratogens</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">NT</TD><TD>+BB2e ethanol &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BB2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BB2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZJ2.10.10.6.2.2e thalidomide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-10-10-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-10-10-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX8"><B>YX8</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>xenobiotics</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX10"><B>YX10</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>environmental pollutants, pesticides</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">RT</TD><TD>+PZ2.4 environmental pollution &nbsp;&nbsp;&nbsp;<A HREF="aodhqpm.htm#PZ2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnpm.htm#PZ2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX10-2">YX10.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>environmental pollutants&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Use this descriptor only when no specific pollutant is given.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX10-4">YX10.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>pesticides&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX10-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>BX8.2 cannabis contaminant &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BX8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BX8-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX10-4-2">YX10.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>herbicides&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX10-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZT4.26.10.2e paraquat &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-26-10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX10-4-4">YX10.4.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>industrial fungicides&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX10-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZJ2.6.10.4.4.4.2e thiram &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-6-10-4-4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-6-10-4-4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX10-4-6">YX10.4.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>insecticides&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX10-4-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX10-4-8">YX10.4.8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>rodenticides&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX10-4-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZT6.8.4.2.2e warfarin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-8-4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-8-4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX10-4-10">YX10.4.10</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pesticide residues&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX10-4-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX10-4-12">YX10.4.12</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pesticide synergists&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX10-4-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX12"><B>YX12</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>toxic industrial waste</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX14"><B>YX14</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>inflammable material</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YX14-2">YX14.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>explosive&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX14-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ"><B><BIG>YZ</BIG></B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B><BIG>miscellaneous substances</BIG></B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#YZ"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">RT</TD><TD>+EBe metabolism &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EB10e drug metabolism &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ2"><B>YZ2</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>catalyst</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">ST</TD><TD> catalyzer, accelerant </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>CL4e catalysis &nbsp;&nbsp;&nbsp;<A HREF="aodhqc.htm#CL4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnc.htm#CL4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ4"><B>YZ4</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>chelating agents</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZO2.12.6e penicillamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO2-12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO2-12-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ6"><B>YZ6</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>food additives</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZC4.2e sodium glutamate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZC4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZC4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+OG food product &nbsp;&nbsp;&nbsp;<A HREF="aodhqo.htm#OG"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhno.htm#OG"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+BX2.2.4e congener &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BX2-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BX2-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ6-2">YZ6.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>food colorants&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD>+YZ10 pigments and dyes &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ6-4">YZ6.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>food flavorings&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">ST</TD><TD> flavoring agents </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+BX2.2.4e congener &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BX2-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BX2-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ6-4-2">YZ6.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>sweetening agents&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ6-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> food sweeteners </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ6-4-2-2">YZ6.4.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>saccharin&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ6-4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ6-4-2-4">YZ6.4.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>aspartame&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ6-4-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ6-6">YZ6.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>flavor enhancers&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ6-8">YZ6.8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>food preservatives&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ6-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZC12.8.6.6e sodium nitrite &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZC12-8-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZC12-8-6-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ8"><B>YZ8</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>dietary fiber</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+ZH8.2.4e cellulose &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZH8-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZH8-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZH8.2.4.2e lignin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZH8-2-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZH8-2-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZH10e pectin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZH10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZH10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+OG food product &nbsp;&nbsp;&nbsp;<A HREF="aodhqo.htm#OG"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhno.htm#OG"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ10"><B>YZ10</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>pigments and dyes</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>YB12.20e riboflavin &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YB12-20"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YB12-20"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZO6.4.12.2e rhodopsin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO6-4-12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO6-4-12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT4.30.2e porphyrins &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-30-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.30.2.2e porphyrinogens &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-30-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.30.2.4e protoporphyrins &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-30-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.30.2.6e uroporphyrins &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-30-2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT4.30.4e bilirubin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-30-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.30.4.2e biliverdin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-30-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.30.6e urobilin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-30-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.30.8e urobilinogen &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-30-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-30-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.10.10e melanin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-10-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT6.18.4e flavins &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-18-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-18-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZU10.8e retinoids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZU10-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzu.htm#ZU10-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZU14.2e carotenoids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZU14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzu.htm#ZU14-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YB8e flavonoids &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YB8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YB8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YZ6.2 food colorants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT6.8.2.2 flavones &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-8-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-8-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ10-2">YZ10.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>retinal pigments&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZO6.4.12.2e rhodopsin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO6-4-12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO6-4-12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZU10.8e retinoids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZU10-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzu.htm#ZU10-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ZU14.2e carotenoids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZU14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzu.htm#ZU14-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ12"><B>YZ12</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>molecular probes</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">NT</TD><TD>+ZS4.4e nucleic acid probes &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZS4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzr.htm#ZS4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+HF26e biological markers &nbsp;&nbsp;&nbsp;<A HREF="aodhqha.htm#HF26"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnha.htm#HF26"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ16"><B>YZ16</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>solvents</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Volatile (i.e., tending to evaporate easily) liquids that are capable of dissolving one or more substances, also referred to as "volatile solvents."  A subclassification of inhalant drugs with a
   large aggregate of chemically diverse substances from a wide variety of sources; many solvents are volatile hydrocarbons.  Typical household solvents include glue (e.g., plastic cement), gasoline,
   paint thinner, nail polish, nail polish remover, and lighter and cleaning fluids.  The active ingredients used in these solvent products include acetone; the chlorated hydrocarbons, such as carbon
   tetrachloride; and the petroleum hydrocarbons (e.g., toluene, benzene, naphtha, and gasoline).  Solvents are CNS depressants, lower heart and breathing rate, and impair judgment and muscle
   coordination.  Like most inhalants, solvents such as glue--the most commonly used--generally produce a brief period of stimulation with giddiness, euphoria, and muscle tremors, followed by a more
   lengthy, dreamlike stupor.  Effects tend to be short-lived and mild.  The petroleum-based solvents, such as paint thinner (e.g., toluene), lighter fluid (e.g., naphtha), and gasoline, generally
   produce the most extreme effects.  Some of their components (e.g., lead) are known to be quite toxic and to cause tissue or nervous system damage.  A major cause of concern is the effect of
   solvents in the sudden sniffing death syndrome.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+BG2 solvent of abuse &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BG2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BG2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YZ18e volatile substances &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ18"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YZ18"><B>YZ18</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>volatile substances</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ18"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="25%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Substances that vaporize at ambient temperatures.  Volatile substances that are inhaled for psychoactive effects (also called inhalants) include the organic solvents present in many domestic and
   industrial products (e.g., glue, aerosol, paints, industrial solvents, lacquer thinners, gasoline, and cleaning fluids) and the aliphatic nitritites, such as amyl nitrite.  Some substances are
   directly toxic to the liver, kidney, or heart; some produce peripheral neuropathy or progressive brain degeneration.  The most frequent users of these substances are young adolescents and street
   children.  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In ICD-10, "volatile solvent use disorders" (F18) are a subclass of the mental and behavioral substance use disorders.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+BGe volatile inhalant &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BG"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BG"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EB10e drug metabolism &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YZ16e solvents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YZ16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YZ16"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
</TABLE><BR><BR>
<CENTER><A HREF="aodob.htm#Y">b-out</A>&nbsp;&nbsp;To Broad Outline&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#YW">d-out</A>&nbsp;&nbsp;To Detailed Outline&nbsp;&nbsp;&nbsp;&nbsp;
<A HREF="aodhqy.htm">qh</A>&nbsp;&nbsp;To Quick Hierarchy</CENTER>
<CENTER><A HREF="aodhnyn.htm">Previous</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm">Next</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodwsrch.htm">Search</A></CENTER><P>classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept </P>
</BODY>
</HTML>
